- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Amgen Inc+ Add to Watchlist
AMGN:US125.4000 USD 3.1400 2.57%
As of 20:10:00 ET on 03/10/2014.
Company Profile for Amgen Inc (AMGN)
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
Key Executives for Amgen Inc (AMGN)
|Robert A Bradway "Bob"Chairman/President/CEO||Michael A KellyActing CFO/VP:Intl Finance|
|Brian M McNameeExec VP:Full Potential Initiatives||Anthony C Hooper "Tony"Exec VP:Commercial Ops|
|Madhavan BalachandranExec VP:Operations||Sean E HarperExec VP:Rsch & Dev|
|David J ScottSenior VP/Secy/Gen Cnsl||Stuart A TrossSenior VP:Human Resources|
|Martin VantriesteSenior VP:Quality||Thomas J W DittrichVP:Finance/Chief Acctg Officer|
|Arvind SoodVP:Investor Relations|